198 related articles for article (PubMed ID: 33931984)
1. Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx?
Rahnama'i MS; Bach C; Schulze-Hagen M; Kuhl CK; Vögeli TA
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1396. PubMed ID: 33931984
[TBL] [Abstract][Full Text] [Related]
2. Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men.
Hendriks RJ; van der Leest MMG; Israël B; Hannink G; YantiSetiasti A; Cornel EB; Hulsbergen-van de Kaa CA; Klaver OS; Sedelaar JPM; Van Criekinge W; de Jong H; Mulders PFA; Crawford ED; Veltman J; Schalken JA; Barentsz JO; van Oort IM
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1110-1119. PubMed ID: 33941866
[TBL] [Abstract][Full Text] [Related]
3. Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy.
Busetto GM; Del Giudice F; Maggi M; De Marco F; Porreca A; Sperduti I; Magliocca FM; Salciccia S; Chung BI; De Berardinis E; Sciarra A
World J Urol; 2021 Jun; 39(6):1869-1877. PubMed ID: 32681273
[TBL] [Abstract][Full Text] [Related]
4. A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.
Hendriks RJ; van der Leest MMG; Dijkstra S; Barentsz JO; Van Criekinge W; Hulsbergen-van de Kaa CA; Schalken JA; Mulders PFA; van Oort IM
Prostate; 2017 Oct; 77(14):1401-1407. PubMed ID: 28853167
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis.
Sari Motlagh R; Yanagisawa T; Kawada T; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Huebner NA; Baltzer PA; Karakiewicz PI; Heidenreich A; Shariat SF
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):187-198. PubMed ID: 35414118
[TBL] [Abstract][Full Text] [Related]
6. Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications.
Yaxley WJ; Nouhaud FX; Raveenthiran S; Franklin A; Donato P; Coughlin G; Kua B; Gianduzzo T; Wong D; Parkinson R; Brown N; Samaratunga H; Delahunt B; Egevad L; Roberts M; Yaxley JW
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):398-405. PubMed ID: 32999464
[TBL] [Abstract][Full Text] [Related]
7. SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study.
Maggi M; Del Giudice F; Falagario UG; Cocci A; Russo GI; Di Mauro M; Sepe GS; Galasso F; Leonardi R; Iacona G; Carroll PR; Cooperberg MR; Porreca A; Ferro M; Lucarelli G; Terracciano D; Cormio L; Carrieri G; De Berardinis E; Sciarra A; Busetto GM
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922626
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI
Pepe P; Dibenedetto G; Pepe L; Pennisi M
In Vivo; 2020; 34(1):393-396. PubMed ID: 31882504
[TBL] [Abstract][Full Text] [Related]
9. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M
Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4-5 index lesions undergoing radical prostatectomy.
Koseoglu E; Kordan Y; Kilic M; Sal O; Seymen H; Kiremit MC; Armutlu A; Ertoy Baydar D; Altinmakas E; Vural M; Falay O; Canda AE; Balbay D; Demirkol MO; Esen T
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):202-209. PubMed ID: 32826958
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic pathway of the biopsy-naïve patient suspected for prostate cancer: Real-life scenario when multiparametric Magnetic Resonance Imaging is not centralized.
Bertolo R; Vittori M; Cipriani C; Maiorino F; Forte V; Iacovelli V; Petta F; Sperandio M; Marani C; Panei M; Travaglia S; Bove P
Prog Urol; 2021 Oct; 31(12):739-746. PubMed ID: 33431200
[TBL] [Abstract][Full Text] [Related]
13. The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy.
Nyk Ł; Tayara O; Ząbkowski T; Kryst P; Andrychowicz A; Malewski W
BMC Urol; 2021 May; 21(1):82. PubMed ID: 34006281
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with SelectMDx® in the diagnosis of prostate cancer in a real-world evidence clinical practice setting.
Quintana LM; Fernández Pascual E; Linares Espinós E; Martinez-Ballesteros C; Martin-Vivas C; Rengifo Abbad D; d'Anna Caruso N; Allona A; Martínez-Salamanca JI
Actas Urol Esp (Engl Ed); 2020; 44(6):400-407. PubMed ID: 32475689
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive comparison between mpMRI of the prostate, MR-US fusion biopsy and whole mount histopathology.
Doblhammer S; Kinger P; Starmuehler M; Muschitz C; Schima W; Susani M; Baierl A; Broessner C
World J Urol; 2023 Apr; 41(4):1055-1060. PubMed ID: 36840753
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
17. Lesion location agreement between prostatic multiparametric magnetic resonance, cognitive fusion biopsy and radical prostatectomy piece.
Lourenço M; Pissarra P; E Brito DV; Eliseu M; Peralta JP; Figueiredo A; Marques C
Arch Ital Urol Androl; 2020 Jan; 91(4):218-223. PubMed ID: 31937086
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI with in-bore targeted biopsy in the diagnostic pathway of prostate cancer: Data from a single institution experience.
Nawfal G; Sarkis J; Assaf S; Mjaess G; Abi Chebel J; Semaan A; Alkassis M; Nemr E; Kamel G; Ayoub N; Sarkis P
Urol Oncol; 2021 Nov; 39(11):781.e9-781.e15. PubMed ID: 33676850
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of
Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the accuracy of multiparametric magnetic resonance imaging (mpMRI) results with the final pathology findings for radical prostatectomy specimens in the detection of prostate cancer.
Lee CH; Ku JY; Park WY; Lee NK; Ha HK
Asia Pac J Clin Oncol; 2019 Apr; 15(2):e20-e27. PubMed ID: 29920966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
